Pharming Group
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Pharming Group and other ETFs, options, and stocks.About PHAR
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema.
CEOFabrice Chouraqui
CEOFabrice Chouraqui
Employees—
Employees—
HeadquartersLeiden, Zuid-Holland
HeadquartersLeiden, Zuid-Holland
Founded1988
Founded1988
Employees—
Employees—
PHAR Key Statistics
Market cap1.15B
Market cap1.15B
Price-Earnings ratio1.16K
Price-Earnings ratio1.16K
Dividend yield—
Dividend yield—
Average volume20.19K
Average volume20.19K
High today$17.19
High today$17.19
Low today$16.46
Low today$16.46
Open price$17.17
Open price$17.17
Volume28.80K
Volume28.80K
52 Week high$17.86
52 Week high$17.86
52 Week low$7.50
52 Week low$7.50
Stock Snapshot
As of today, Pharming Group(PHAR) shares are valued at $16.75. The company's market cap stands at 1.15B, with a P/E ratio of 1163.19.
On 2025-12-07, Pharming Group(PHAR) stock moved within a range of $16.46 to $17.19. With shares now at $16.75, the stock is trading +1.7% above its intraday low and -2.6% below the session's peak.
Trading activity shows a volume of 28.8K, compared to an average daily volume of 20.19K.
Over the past 52 weeks, Pharming Group(PHAR) stock has traded between a high of $17.86 and a low of $7.50.
Over the past 52 weeks, Pharming Group(PHAR) stock has traded between a high of $17.86 and a low of $7.50.